Peritoneal Tumors of Mullerian Origin: A Case Report and Review of the Literature
Main Article Content
Abstract
Primary peritoneal tumors share a common anatomical site and therefore their clinical manifestations are very similar. When peritoneal masses are detected, the tentative initial diagnosis is secondary to metastatic disease, which has been determined most frequently in the peritoneal cavity. However, primary peritoneal tumors should always be included in the differential diagnosis. Among the primary malignant peritoneal neoplasms, mesothelial tumors have been identified (malignant mesothelioma, well-differentiated papillary mesothelioma, benign cystic mesothelioma, adenomatoid tumor of the peritoneum), epithelial-type tumors (primary peritoneal serous carcinoma, primary peritoneal serous borderline tumor), tumors of the smooth muscle (disseminated peritoneal leiomyomatosis) and tumors of uncertain or undetermined origin (desmoplastic small round cell tumor, peritoneal solitary fibrous tumor).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28(2):583-607; quiz 212.
II. McLaughlin PD, Filippone A, Maher MM. Neoplastic diseases of the peritoneum and mesentery. AJR Am J Roentgenol. 2013;200(5): W420-30.
III. Raptopoulos V, Gourtsoyiannis N. Peritoneal carcinomatosis. Eur Radiol. 2001;11(11):2195-206.
IV. Pickhardt PJ, Bhalla S. Primary neoplasms of peritoneal and sub-peritoneal origin: CT findings. Radiographics. 2005;25(4):983-95.
V. Marin D, Catalano C, Baski M, Di Martino M, Geiger D, Di Giorgio A, et al. 64-Section multidetector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging. 2010;35(6):694-700.
VI. Siewert B, Sosna J, McNamara A, Raptopoulos V, Kruskal JB. Missed lesions at abdominal oncologic CT: lessons learned from quality assurance. Radiographics. 2008;28(3):623-38.
VII. Macari M, Megibow AJ, Balthazar EJ. A pattern approach to the abnormal small bowel: observations at MDCT and CT enterography. AJR Am J Roentgenol. 2007;188(5):1344-55.
VIII. Funicelli L, Travaini LL, Landoni F, Trifiro G, Bonello L, Bellomi M. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [(1)(8)F]FDG-PET/CT. Abdom Imaging.
;35(6):701-7.
IX. Metser U, You J, McSweeney S, Freeman M, Hendler A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol.
;194(3):76671.
X. Anthony MP, Khong PL, Zhang J. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease. AJR Am J Roentgenol. 2009;193(6):W523-9.
XI. Elsayes KM, Staveteig PT, Narra VR, Leyendecker JR, Lewis JS, Jr., Brown JJ. MRI of the peritoneum: spectrum of abnormalities. AJR Am J Roentgenol. 2006;186(5):1368-79.
XII. Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, et al. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol. 2011;196(2):447-53.
XIII. Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM. Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics. 2010;30(5):1269-85.
XIV. Fujii S, Matsusue E, Kanasaki Y, Kanamori Y, Nakanishi J, Sugihara S, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2008;18(1):18-23.
XV. Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics. 2009;29(3):759-74; discussion 74-8.
XVI. Kyriazi S, Collins DJ, Messiou C, Pennert K, Davidson RL, Giles SL, et al. Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients. Radiology. 2011;261(1):182-92.
XVII. Oei TN, Jagannathan JP, Ramaiya N, Ros PR. Peritoneal sarcomatosis versus peritoneal carcinomatosis: imaging findings at MDCT. AJR Am J Roentgenol. 2010;195(3):W229-35.
XVIII. Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29(2):347-73.
XIX. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol.
;18(6):985-90.
XX. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26(2):55-65.
XXI. Churg A. Tumors of the serosal membranes. pathology. Aaot, editor: Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology, 2006.; 2006.
XXII. Society AC. Cancer Facts & Figures 2011. Atlanta, GA: American Cancer Society, 2011.
XXIII. 23.Tavassoli FA. Pathology and genetics of tumours of the breast and female genital organs. Lyon, France: IARC; 2003.
XXIV. Meyers M. Meyers' dynamic radiology of the abdomen: normal and pathologic anatomy. New York Springer; 2011.
XXV. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol. 1988;6(1):147-53.